Catalogo dei prodotti della ricerca

MANDELLI, Franco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.950
AS - Asia 14.334
EU - Europa 8.175
SA - Sud America 2.371
AF - Africa 418
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 13
Totale 49.293
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.404
SG - Singapore 5.939
CN - Cina 2.530
IT - Italia 2.475
BR - Brasile 1.829
VN - Vietnam 1.611
IN - India 1.514
HK - Hong Kong 1.416
SE - Svezia 1.149
FI - Finlandia 834
UA - Ucraina 755
DE - Germania 626
FR - Francia 556
RU - Federazione Russa 540
BD - Bangladesh 421
GB - Regno Unito 314
CA - Canada 313
AR - Argentina 249
RO - Romania 215
IE - Irlanda 151
IQ - Iraq 136
ZA - Sudafrica 131
BG - Bulgaria 116
JP - Giappone 114
MX - Messico 97
EC - Ecuador 82
NL - Olanda 71
TR - Turchia 71
ID - Indonesia 68
PK - Pakistan 66
SA - Arabia Saudita 60
MA - Marocco 57
GR - Grecia 56
BE - Belgio 52
PL - Polonia 51
KR - Corea 49
VE - Venezuela 42
ES - Italia 40
PH - Filippine 40
AT - Austria 37
CO - Colombia 37
CL - Cile 35
PY - Paraguay 35
UZ - Uzbekistan 35
CI - Costa d'Avorio 34
KE - Kenya 34
TN - Tunisia 32
TG - Togo 31
JO - Giordania 28
JM - Giamaica 26
UY - Uruguay 25
PE - Perù 24
AE - Emirati Arabi Uniti 22
DO - Repubblica Dominicana 20
EG - Egitto 20
IR - Iran 20
AU - Australia 19
CH - Svizzera 19
MY - Malesia 19
AZ - Azerbaigian 18
CR - Costa Rica 18
IL - Israele 18
NP - Nepal 17
KZ - Kazakistan 16
TT - Trinidad e Tobago 16
LT - Lituania 15
TW - Taiwan 15
DZ - Algeria 14
ET - Etiopia 14
HN - Honduras 14
OM - Oman 13
TH - Thailandia 13
AL - Albania 12
BO - Bolivia 12
LB - Libano 12
NZ - Nuova Zelanda 12
DK - Danimarca 10
EU - Europa 10
RS - Serbia 10
NI - Nicaragua 9
HR - Croazia 8
LV - Lettonia 8
MD - Moldavia 8
NG - Nigeria 8
PA - Panama 8
SN - Senegal 8
BY - Bielorussia 7
CZ - Repubblica Ceca 7
QA - Qatar 7
AO - Angola 6
GT - Guatemala 6
MN - Mongolia 6
PS - Palestinian Territory 6
PT - Portogallo 6
SC - Seychelles 6
SY - Repubblica araba siriana 6
BH - Bahrain 5
EE - Estonia 5
BS - Bahamas 4
CG - Congo 4
Totale 49.209
Salva come PNG Salva come JPEG
Città #
Singapore 3.007
Fairfield 2.269
Ashburn 2.233
Chandler 1.442
San Jose 1.430
Hong Kong 1.363
Woodbridge 1.205
Houston 941
Princeton 867
Wilmington 821
Seattle 783
Ann Arbor 758
Cambridge 726
Beijing 629
Plano 606
San Paolo di Civitate 521
Ho Chi Minh City 502
The Dalles 465
Dallas 460
Los Angeles 460
Lauterbourg 457
Santa Clara 414
Hanoi 411
Des Moines 394
Rome 390
Boston 382
Lawrence 341
Buffalo 301
Millbury 256
Frankfurt am Main 242
Dearborn 235
Jacksonville 230
Helsinki 224
Milan 216
San Diego 200
Andover 185
New York 169
Redondo Beach 156
São Paulo 145
Toronto 132
Dublin 128
Moscow 128
Norwalk 123
Sofia 113
Federal 98
Tokyo 93
Boardman 88
Johannesburg 75
Falkenstein 74
Rio de Janeiro 72
Ottawa 71
Guangzhou 69
Southend 67
Munich 66
Chicago 64
Orem 63
Falls Church 62
Yubileyny 61
Da Nang 60
Bremen 59
Haiphong 59
Shanghai 58
Columbus 57
Hillsboro 55
Hefei 53
Baghdad 50
Nanjing 50
Brussels 49
Council Bluffs 49
Miano 47
Florence 44
Belo Horizonte 42
Bühl 42
Brooklyn 41
Dhaka 41
Cosenza 40
San Mateo 40
Brasília 39
Kunming 39
Atlanta 38
Cagliari 38
London 38
Nuremberg 38
Warsaw 35
Abidjan 34
Biên Hòa 33
Campinas 33
Curitiba 33
Mannheim 33
Nairobi 32
Tianjin 32
Bologna 31
Phoenix 31
Tashkent 31
Bengaluru 30
Lomé 30
Montreal 30
Hải Dương 29
Naples 29
Turku 28
Totale 30.183
Salva come PNG Salva come JPEG
Nome #
Emolinfopatie Maligne 696
High dose cytarabine and idarubicin for the treatment of advanced acute lymphoblastic leukemia 313
Mitoxantrone, Etoposide e dosi intermedie di ARA-C (protocollo MEC) nel trattamento della leucemia acuta mieloide (LAM) del bambino refrattario o in recidiva 198
A CRM-Positive variant of factor-VII deficiency and the detection of heterozygotes with the assay of factor-like antigen. 196
Kinetic features of Lin-/CD34- and Lin-/CD34+ stem cells from normal donors and chronic myeloid leukemia (CML) patients. 182
ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DESCRIPTION AND ANALYSIS OF LONG TERM SURVIVORS. A RETROSPECTIVE STUDY 178
Drug use and acute leukemia. 163
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol 160
BAVC regimen and autograft for acute myelogenous leukemia in second complete remission 159
Alte dosi di ARA-C + Idarubicina nel trattamento della leucemia linfoide acuta in fase avanzata 158
High-dose hydroxyurea in the treatment of poor-risk myeloid leukemias 155
A single high dose of idarubicin combined with high-dose ARA-C for treatment of first relapse in childhood 'high-risk' acute lymphoblastic leukaemia: a study of the AIEOP group. 155
A gender-based score system predicts the clinical outcome of patients with early B-cell chronic lymphocytic leukemia 155
Clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/ENL fusion gene 149
Y chromosome duplication: a minor route evolutive pattern in CML. 149
Acute myeloid leukemia and lung cancer occurring in a chronic lymphocytic leukemia patient treated with fludarabine and autologous peripheral blood stem-cell transplantation 149
Acute myeloid leukemia in patients previously diagnosed with breast cancer: Experience of the GIMEMA group 147
CODOX-M/IVAC (NCI 89-C-41) in children and adolescents with Burkitt's leukemia/lymphoma and large B-cell lymphomas: A 15-year monocentric experience. 145
A case of Burkitt lymphoma-L3 ALL with t(8;14)translocation, developed 10 years after Hodgkin's disease. 145
Randomized Phase III trial of retinoic acid and arsenic trioxide versus retinoic acid and chemotherapy in patients with acute promyelocytic leukemia: Health-related quality-of-life outcomes 144
A single high dose of idarubicin combined with high-dose ABA-C (MSKCC ALL-3 protocol) in adult and pediatric patients with acute lymphoblastic leukemia. Experience at the University La Sapienza of Rome. 142
SUSTAINED MOLECULAR REMISSION AFTER LOW DOSE GEMTUZUMAB-OZOGAMICIN IN ELDERLY PATIENTS WITH ADVANCED ACUTE PROMYELOCYTIC LEUKEMIA 141
Acute myelogenous leukemia in first relapse treated with two consecutive autologous bone marrow transplantations: A pilot study 141
Secondary acute myeloid leukaemia: results of conventional treatments. Experience of GIMEMA trials 141
The therapeutic response and clinical outcome of adults with ALL1(MLL)/AF4 fusion positive acute lymphoblastic leukemia according to the GIMEMA experience. 140
Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin (NPM1) 140
POLYCLONAL HEMATOPOIETIC RECONSTITUTION IN LEUKEMIA PATIENTS AT REMISSION AFTER SUPPRESSION OF SPECIFIC GENE REARRANGEMENTS 139
Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial 137
Myelodysplastic syndromes in patients under 50 years old: a single institution experience 137
Acute myelogenous leukemia in elderly patients not elegible for intensive chemotherapy: the dark side on the moon. 136
COMBINATION OF CYTOSINE-ARABINOSIDE (ARA-C), CYCLOPHOSPHAMIDE AND PREDNISONE IN THE TREATMENT OF B-CHRONIC LYMPHOCYTIC-LEUKEMIA IN ADVANCED STAGES AND PROGRESSIVE DISEASE 136
Patient- versus physician-reporting of symptoms and health status in chronic myeloid leukemia 136
Leucemia acuta promielocitica del bambino: risultati del protocollo nazionale AIDA (LAP 0493) 136
GIMEMA-AIEOP AIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children. 136
BLOOD COAGULATION ABNORMALITIES IN CHRONIC MYELOID LEUKAEMIA. 135
Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience 135
Epidemiology, features and outcome of pain in patients with advanced hematological malignancies followed in a home care program: An Italian survey 135
Apoptosis susceptibility and cell-cycle distribution in cells from myelodysplastic syndrome patients: modulatory in-vitro effects of G-CSF and Interferon-alpha 134
Chronic lymphocytic leukemia: studies on the effect of drug treatment on different lymphocytic subpopulations 133
Prognostic impact of genetic characterization in the GIMEMA LAM99P multicenter study for newly diagnosed acute myeloid leukemia 133
Efficacy of the BEACOPP regimen in refractory and relapsed Hodgkin lymphoma. 132
a prospective study of a-interferon and autologus bone marrow transplantation in chronic myeloid leukemia 132
Allogeneic, but not autologous, hematopoietic cell transplantation improves survival only among younger adults with acute lymphoblastic leukemia in first remission: An individual patient data meta-analysis 132
Evaluation of therapeutic modalities in the control of Hodgkin's disease. 131
High-Dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: Results of the EORTC-GIMEMA AML-12 trial 131
Flt3L induces the ex vivo amplification of umbilical cord blood committed progenitors and early stem cells in short term cultures. 130
HLA typing in Hairy Cell Leukemia (HCL): report of a familial HCL and an association of HCL and Chronic Lymphocitic Leukemia (CLL). 130
Aspergillus colonization of the nose and pulmonary aspergillosis in neutropenic patients: a retrospective study. 129
Ablative chemotherapy followed by peripheral-blood stem-cell reinfusion for chronic myelogenous leukemia chronic phase 129
A single high dose of idarubicin combined with high-dose ARA-C (MSKCC ALL-3 protocol) in adult and pediatric patients with acute lymphoblastic leukemia. Experience at the University "La Sapienza" of Rome. 129
Elderly patients with PH+ chronic myelogenous leukemia (CML): Results of imatinib mesylate treatment 129
Adhesion molecule expression on B-cell chronic lymphocytic leukemia cells: malignant cell phenotypes define distinct disease subsets 128
B-cell acute lymphoid leukemia (ALL) with lymphoblasts expressing surface immunoglobulins only at relapse. 128
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia 128
Feasibility and results of a multimodality approach in elderly patients with localized intermediate to high-grade non-Hodgkin's lymphomas 128
Liposomal daunorubicin versus standard daunorubicin: long term follow-up of the GIMEMA GSI 103 AMLE randomized trial in patients older than 60 years with acute myelogenous leukaemia. 128
Obesity and autologous stem cell transplantation in acute myeloid leukemia 126
Health-related quality of life assessment and reported outcomes in leukaemia randomised controlled trials - a systematic review to evaluate the added value in supporting clinical decision making. 125
Standard conditioning regimen and T-depleted donor bone marrow for transplantation in chronic myeloid leukemia 125
Clonal evolution in Philadelphia chromosome negative cells following successful treatment with imatinib of a CML patient: clinical and biological features of a myelodysplastic syndrome 125
Asymptomatic carriage of Cryptosporidium in two patients with leukemia. 124
Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: Results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol 124
Transcription of latent and replicative Epstein-Barr virus genes in bone marrow and peripheral blood mononuclear cells of healthy donors. 123
COAGULATION STUDY IN PATIENTS WHO HAD UNDERGONE SURGERY FOR MENINGIOMA 122
Late relapses in acute promyelocytic leukaemia 122
a-Interferon as maintenance drug after initial fludarabine therapy for patients with chronic lymphocitic leukemia and low grade non-Hodgkin's lymphoma 122
p53 expression in B-cell chronic lymphocytic leukemia: A marker of disease progression and poor prognosis 122
Conventional salvage chemotherapy vs. high-dose therapy with autografting for recurrent or refractory Hodgkin's disease patients 122
Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival 121
ASCORBIC ACID FOR THE TREATMENT OF AUTOIMMUNE THROMBOCYTOPENIC PURPURA 121
A single high dose of idarubicin combined with high dose ARA-C for the treatment of first recurrence childhood “high risk” acute lymphoblastic leukemia (ALL). 121
Developing a European network for adult ALL. 120
GIMEMA-AIEOP AIDA protocols for the treatment of newly diagnosed acute promyelocytic leukemia APL) in children: analysis of patients enrolled in two sequential Italian multicenter trials 120
Partial deletions of long arm of chromosome 6: Biologic and clinical implications in adult acute lymphoblastic leukemia 120
Health-related quality of life and symptom assessment in clinical research of patients with hematologic malignancies: Where are we now and where do we go from here? 119
Intensive consolidation therapy compared with standard consolidation and maintenance therapy for adults with acute myeloid leukaemia aged between 46 and 60 years: final results of the randomized phase III study (AML 8B) of the European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. 119
Acute lymphoblastic leukemia (ALL) primary refractory or in first relapse: results in children and adults over a 20-year period 119
Umbilical cord blood transplant from unrelated HLA-mismatched donors in children with high risk leukemia 119
Acute promyelocytic leukemia (APL) in children: results of the AIDA Italian protocol. 119
Breast Cancer Resistance Protein (BCRP) expression affect event-free survival in adult acute lymphoblastic leukemia patients. 118
Mediastinal large B-cell lymphoma: clinical and immunohistological findings in 18 patients treated with different third-generation regimens. 118
Conservative treatment for patients over 80 years with acute myelogenous leukemia 117
Outpatient management of acute promyelocytic leukemia after consolidation chemotherapy. 117
Second malignancy after treatment of adult acute myeloid leukemia: cohort study on adult patients enrolled in the GIMEMA trials 117
Interleukin-3 priming in acute myeloid leukaemia patients 117
Imatinib mesylate may improve fasting blood glucose in diabetic Ph+ chronic myelogenous leukemia patients responsive to treatment. 117
Factor VII deficiency: Immunological characterization of genetic variants and detection of carriers 117
Gemtuzumab ozogamicin (Mylotarg) as single-agent treatment for frail patients 61 years of age and older with acute myeloid leukemia: final results of AML-15B, a phase 2 study of the European Organisation for Research and Treatment of Cancer and Gruppo Italiano Malattie Ematologiche dell'Adulto Leukemia Groups. 116
Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by (67)Gallium scan in 50 patients 115
Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features 115
ERK1/2 phosphorylation is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia 115
Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial 114
AUTOIMMUNE THROMBOCYTOPENIC PURPURA :MATERNAL AND FETAL DISEASE 114
MDR1 protein expression is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia. 114
Tyrosine-kinase inhibitors and patient-reported outcomes in chronic myeloid leukemia: a systematic review. 113
Adolescent and adult acute lymphoblastic leukemia: Prognostic features and outcome of therapy. A study of 293 patients 113
PHASE-III COMPARATIVE TRIAL USING CHOP VS CIOP IN THE TREATMENT OF ADVANCED INTERMEDIATE-GRADE NON-HODGKINS-LYMPHOMA 113
Prolonged effect of alpha Interferon after discontinuance of treatment in chronic myelogenous leukemia patients. 112
A pilot GIMEMA study of liposomal daunorubicin plus cytosine arabinoside for elderly patients with acute myeloid leukemia, 112
Health-Related Quality of Life in Patients with Primary Immune Thrombocytopenia (pITP): Investigating Differences Amongst Newly Diagnosed, Persistent and Chronic Pitp Patients 112
Totale 13.929
Salva come PNG Salva come JPEG
Categoria #
all - tutte 140.034
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 140.034
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.641 19 381 418 409 815 122 112 481 376 527 690 1.291
2022/20235.905 1.450 1.198 183 594 519 859 119 280 473 51 146 33
2023/20241.955 156 284 77 119 98 108 44 310 5 278 196 280
2024/20257.570 264 323 326 114 351 432 492 290 1.288 939 494 2.257
2025/202617.129 1.733 995 1.340 1.506 1.828 1.236 2.036 966 1.622 1.745 1.066 1.056
2026/2027744 744 0 0 0 0 0 0 0 0 0 0 0
Totale 49.973